2025
SJR Q2
JCR Q3 · 1,5
213 eşleşen makale
SCIE
Dergi ayrıntısı
Heart and Vessels
- Yayıncı
- Springer
- Ülke
- Japan · Asiatic Region
- Tür
- journal
- ISSN
-
0910832716152573
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,546
- Quartile Q2
- H-Index 57
- Atıf/yayın 1,57
- Doküman (3y) 527
- Atıf (3y) 808
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,5
- 5Y JIF 1,4
- JCI 0,41
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
Alanlar
WoS kategorileri
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,546 | 1,5 | 1,4 | 0,41 | Q3 | 57 |
| 2024 | Q3 | Q3 | 0,494 | 1,5 | 1,4 | 0,41 | Q3 | 55 |
| 2023 | Q2 | Q3 | 0,574 | 1,4 | 1,4 | 0,4 | Q3 | 55 |
| 2022 | Q2 | Q4 | 0,567 | 1,5 | 1,6 | 0,39 | Q3 | 55 |
| 2021 | Q2 | Q4 | 0,551 | 1,8 | 1,7 | 0,41 | Q3 | 55 |
| 2020 | Q2 | Q3 | 0,624 | 2 | 1,8 | 0,47 | Q3 | 55 |
| 2019 | Q2 | Q4 | 0,555 | 1,6 | 1,4 | 0,51 | Q2 | 55 |
| 2018 | — | Q3 | — | 1,6 | 1,5 | 0,57 | Q2 | — |
| 2017 | Q2 | Q3 | 0,894 | 2,2 | 1,8 | 0,69 | Q2 | 55 |
| 2016 | Q2 | Q2 | 0,83 | 3,4 | 2,5 | — | — | 55 |
| 2015 | Q2 | Q2 | 0,815 | 2,3 | 1,8 | — | — | 55 |
| 2014 | Q2 | Q3 | 0,729 | 2,1 | 1,8 | — | — | 55 |
| 2013 | Q2 | Q3 | 0,758 | 2,1 | 1,8 | — | — | 55 |
| 2012 | Q2 | Q3 | 0,788 | 2,1 | 1,7 | — | — | 55 |
| 2011 | Q1 | Q3 | 0,94 | 2 | 1,6 | — | — | 55 |
| 2010 | Q2 | Q3 | 0,707 | 1,9 | 1,5 | — | — | 55 |
| 2009 | — | Q3 | — | 1,7 | 1,4 | — | — | — |
| 2008 | — | Q3 | — | 1,4 | 1,3 | — | — | — |
| 2007 | — | Q4 | — | 1 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1,3 | — | — | — | — |
| 2004 | — | Q4 | — | 0,8 | — | — | — | — |
| 2003 | — | Q4 | — | 0,4 | — | — | — | — |
| 2002 | — | Q4 | — | 0,7 | — | — | — | — |
| 2001 | — | Q4 | — | 0,3 | — | — | — | — |
| 2000 | — | Q4 | — | 0,6 | — | — | — | — |
| 1999 | — | Q4 | — | 0,3 | — | — | — | — |
| 1998 | — | Q4 | — | 0,2 | — | — | — | — |
| 1997 | — | Q4 | — | 0,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 162/237 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 75/100 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 149/231 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 73/98 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 152/222 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 72/96 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 125/143 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/68 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 118/143 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 56/67 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 106/142 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 52/65 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q2 | 104/138 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 54/65 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 101/136 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q2 | 51/65 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 69/128 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 40/65 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 46/126 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/63 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 58/124 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/63 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 64/123 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 43/60 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 66/125 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/65 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 63/124 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 37/68 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 61/117 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 38/68 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 60/114 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 39/68 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 52/95 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 38/61 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 53/79 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 41/56 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 59/75 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 42/54 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 55/74 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 40/52 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 42/72 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/51 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 54/71 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 45/51 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 63/70 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 46/52 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 55/66 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 42/52 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 61/65 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 46/50 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 49/63 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 37/45 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 57/67 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 41/44 |
| 1998 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 60/62 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 39/39 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 56/62 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 36/38 |